adamantane has been researched along with Precursor Cell Lymphoblastic Leukemia-Lymphoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chandra, J; Cheng, T; Donnella, H; Irwin, ME; Rivera-Del Valle, N; Singh, MM | 1 |
| Bendall, LJ; Bradstock, KF; Pitson, SM; Powell, JA; Tong, D; Wallington-Beddoe, CT | 1 |
2 other study(ies) available for adamantane and Precursor Cell Lymphoblastic Leukemia-Lymphoma
| Article | Year |
|---|---|
Combinatorial effects of histone deacetylase inhibitors (HDACi), vorinostat and entinostat, and adaphostin are characterized by distinct redox alterations.
Topics: Adamantane; Antineoplastic Agents; Apoptosis; Benzamides; Cell Line, Tumor; DNA Fragmentation; Drug Therapy, Combination; Gene Expression Profiling; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Hydroquinones; Oxidation-Reduction; Oxidative Stress; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyridines; Vorinostat | 2018 |
Sphingosine kinase 2 promotes acute lymphoblastic leukemia by enhancing MYC expression.
Topics: Acetylation; Adamantane; Animals; Caspases; Cell Death; Cell Growth Processes; Enzyme Inhibitors; Gene Expression Regulation, Leukemic; Genes, myc; HEK293 Cells; Histones; Humans; K562 Cells; Mice; Mice, Inbred NOD; Mice, SCID; Mice, Transgenic; Phosphotransferases (Alcohol Group Acceptor); Precursor Cell Lymphoblastic Leukemia-Lymphoma; Promoter Regions, Genetic; Proto-Oncogene Proteins c-myc; Pyridines; Xenograft Model Antitumor Assays | 2014 |